Genetics Adviser - Coming Soon!

The Human Genetics Society of Australasia (HGSA) Genetics Adviser point-of-care tool will support clinicians and patients in Australia through the informed consent process for mainstream genetic testing in cancer care. The Genetics Adviser tool is coming soon to this website, so please watch this space!

Mainstreaming Modules Have Moved!

Updated educational modules Mainstreaming genetic testing for oncology teams: A focus on genetic testing in cancer patients | eviQ Education are now live!

Mainstream genetic testing in patients with cancer is performed through the patient’s own oncology team during their existing oncology appointments, with support as required from a genetic service.¹ This new and updated suite of learning modules is designed to support all members of the oncology team (including surgeons, oncologists, and cancer nurses) to deliver genetic testing to cancer patients. The main module applies across cancer types, with tumour-specific modules available for breast and ovarian cancer.

These modules, developed by the joint Clinical Oncology Society of Australia and Human Genetics Society of Australasia Cancer Genetics Special Interest Group (COSA/HGSA Cancer Genetics SIG), are an update to the 2019 learning module developed by the Mainstreaming Working Group for the COSA Familial Cancer SIG. This project was supported by funding from Astra Zeneca and development provided by The Med Collective. All content and ownership remain independently with the COSA HGSA Cancer SIG.

Feedback to the Cancer Genetics SIG is welcomed through the HGSA Secretariat, secretariat@hgsa.org.au or by emailing projectofficer@hgsa.org.au.